Shu-Peng Ho

1.1k citations
36 papers · 841 indexed · h-index 16
Topics
Nerve injury and regeneration (7 papers)Mesenchymal stem cell research (4 papers)Immunotherapy and Immune Responses (3 papers)

In The Last Decade

Shu-Peng Ho

36 papers receiving 810 citations

Peers

Shu-Peng Ho
Comparison fields: 5 of 104
  • Molecular Biology 303
  • Cellular and Molecular Neuroscience 204
  • Genetics 162
  • Surgery 161
  • Biomedical Engineering 110
Replace Jong‐Hwan Lee with:
Jong‐Hwan Lee South Korea
Sofia C. Serra Portugal
Andrew R. Reeves United States
Zheng Cao China
Oliver Dreesen Singapore
Seungkwon You South Korea
Lin Yu China
Buom‐Yong Ryu South Korea
Mohammad Mehdi Yaghoobi Iran
Mengmeng Yang China
Shu-Peng Ho relative to Jong‐Hwan Lee South Korea Jong‐Hwan Lee's profile →
Citations per field
00.5×1.7×
Jong‐Hwan Lee · 1×
Citations per year

Countries citing papers authored by Shu-Peng Ho

Since Specialization
Citations

This map shows the geographic impact of Shu-Peng Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu-Peng Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu-Peng Ho more than expected).

Fields of papers citing papers by Shu-Peng Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu-Peng Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu-Peng Ho. The network helps show where Shu-Peng Ho may publish in the future.

Co-authorship network of co-authors of Shu-Peng Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Shu-Peng Ho. A scholar is included among the top collaborators of Shu-Peng Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu-Peng Ho. Shu-Peng Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 5
3 32
4 3
5 1
6 11
7 9
8 10
9 12
10 42
11 55
12 18
13 57
14 97
15 119
16 12
17 15
18 9
19 14
20 14

About Shu-Peng Ho

Shu-Peng Ho is a scholar working on Developmental Neuroscience, Cellular and Molecular Neuroscience and Immunology, having authored 36 papers that have together received 841 indexed citations. Recurring topics across this work include Nerve injury and regeneration (7 papers), Mesenchymal stem cell research (4 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Genetics (162 citations), Developmental Neuroscience (58 citations) and Cellular and Molecular Neuroscience (204 citations). Shu-Peng Ho has collaborated with scholars based in Taiwan, United States and Indonesia. Frequent co-authors include Hung-Chuan Pan, Fu‐Chou Cheng, Dar‐Yu Yang, Shyh‐Horng Chiou, Ming‐Hong Chang, Chao‐Ming Wang, Chun‐Jung Chen, Shiaw‐Min Hwang, Minghui Chen and Ching‐Lin Shyu. Their work appears in journals such as Neurosurgery, Toxicology and Applied Pharmacology and Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026